Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients

Background - Precise molecular characterization of breast cancer, especially triple negative (TNBC) as the most lethal subtype, is needed to stratify patients for the individual treatment approach. MicroRNA-205 (miR-205) has tumor-suppressive and oncogenic functions across different cancers. Therefo...

Full description

Saved in:
Bibliographic Details
Main Authors: Petrović, Nina (Author) , Todorović, Lidija (Author) , Nedeljković, Milica (Author) , Božović, Ana (Author) , Bukumirić, Zoran (Author) , Tanić, Nasta Dedović (Author) , Jovanović-Ćupić, Snežana (Author) , Šami, Ahmad (Author) , Mandušić, Vesna (Author)
Format: Article (Journal)
Language:English
Published: 17 August 2022
In: Pathology, research and practice
Year: 2022, Volume: 238, Pages: 1-8
ISSN:1618-0631
DOI:10.1016/j.prp.2022.154080
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.prp.2022.154080
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0344033822003247
Get full text
Author Notes:Nina Petrović, Lidija Todorović, Milica Nedeljković, Ana Božović, Zoran Bukumirić, Nasta Dedović Tanić, Snežana Jovanović-Ćupić, Ahmad Šami, Vesna Mandušić

MARC

LEADER 00000caa a2200000 c 4500
001 1856822877
003 DE-627
005 20240329080419.0
007 cr uuu---uuuuu
008 230821s2022 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.prp.2022.154080  |2 doi 
035 |a (DE-627)1856822877 
035 |a (DE-599)KXP1856822877 
035 |a (OCoLC)1425216995 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Petrović, Nina  |e VerfasserIn  |0 (DE-588)129980456X  |0 (DE-627)1856823873  |4 aut 
245 1 0 |a Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients  |c Nina Petrović, Lidija Todorović, Milica Nedeljković, Ana Božović, Zoran Bukumirić, Nasta Dedović Tanić, Snežana Jovanović-Ćupić, Ahmad Šami, Vesna Mandušić 
264 1 |c 17 August 2022 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 17 August 2022, Artikelversion: 19 August 2022 
500 |a Gesehen am 21.08.2023 
520 |a Background - Precise molecular characterization of breast cancer, especially triple negative (TNBC) as the most lethal subtype, is needed to stratify patients for the individual treatment approach. MicroRNA-205 (miR-205) has tumor-suppressive and oncogenic functions across different cancers. Therefore, miR-205 might have a different role in TNBC and estrogen receptor (ER) positive BC. Our aim was to investigate how miR-205 expression is associated with ER/progesteron receptor status, clinical parameters, pathohistological characteristics of BC, and survival of patients - Methods - We determined miR-205 relative expressions in 73 primary breast tumors (50 TNBC and 23 ER+) by quantitative Real-time polymerase chain reaction (qPCR) and compared it to clinicopathological characteristics and outcome. - Results - The highest levels of miR-205 were in the ER+ /PR+ group, and the lowest in the TNBC group (p = 0.009). Significantly higher levels of miR-205 were also observed in the ER+ compared with the ER-negative group, regardless of the PR status (p = 0.002). Low miR-205 expression level was associated with prognostic stage III in TNBC samples (p = 0.049). Patients who received adjuvant chemotherapy had significantly lower levels of miR-205 (p = 0.016). Patients who received hormone therapy had significantly higher levels of miR-205 (p = 0.007). The low-miR-205 patients had significantly higher 5-year survival rates (p = 0.041). - Conclusion - The expression of miR-205 in BC is subtype-specific and high expression is associated with the ER+ tumors. The miR-205 expression might be a useful marker of TNBC progression. High miR-205 expression had a detrimental effect on BC patient outcome. Our results indicate that miR-205 might be utilized in clinical practice as a biomarker and an adjunct parameter for the selection of the most effective therapeutic modality. 
650 4 |a Chemotherapy 
650 4 |a Estrogen receptor-positive breast cancer 
650 4 |a Hormone therapy 
650 4 |a MiR-205 
650 4 |a Survival 
650 4 |a Triple-negative breast cancer 
700 1 |a Todorović, Lidija  |e VerfasserIn  |4 aut 
700 1 |a Nedeljković, Milica  |e VerfasserIn  |4 aut 
700 1 |a Božović, Ana  |e VerfasserIn  |4 aut 
700 1 |a Bukumirić, Zoran  |e VerfasserIn  |4 aut 
700 1 |a Tanić, Nasta Dedović  |e VerfasserIn  |4 aut 
700 1 |a Jovanović-Ćupić, Snežana  |e VerfasserIn  |0 (DE-588)1231743735  |0 (DE-627)1755360223  |4 aut 
700 1 |a Šami, Ahmad  |d 1987-  |e VerfasserIn  |0 (DE-588)1230516158  |0 (DE-627)1752986636  |4 aut 
700 1 |a Mandušić, Vesna  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Pathology, research and practice  |d München : Elsevier, 1978  |g 238(2022) vom: Okt., Artikel-ID 154080, Seite 1-8  |h Online-Ressource  |w (DE-627)325789517  |w (DE-600)2039756-2  |w (DE-576)094480672  |x 1618-0631  |7 nnas  |a Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients 
773 1 8 |g volume:238  |g year:2022  |g month:10  |g elocationid:154080  |g pages:1-8  |g extent:8  |a Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients 
856 4 0 |u https://doi.org/10.1016/j.prp.2022.154080  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0344033822003247  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230821 
993 |a Article 
994 |a 2022 
998 |g 1230516158  |a Šami, Ahmad  |m 1230516158:Šami, Ahmad  |d 60000  |d 63000  |e 60000PS1230516158  |e 63000PS1230516158  |k 0/60000/  |k 1/60000/63000/  |p 8 
999 |a KXP-PPN1856822877  |e 4368607228 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.prp.2022.154080"],"eki":["1856822877"]},"relHost":[{"id":{"zdb":["2039756-2"],"issn":["1618-0631"],"eki":["325789517"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["162.1978 -"],"recId":"325789517","note":["Gesehen am 23.01.2018"],"title":[{"title":"Pathology, research and practice","title_sort":"Pathology, research and practice"}],"origin":[{"publisherPlace":"München ; Jena","dateIssuedDisp":"1978-","dateIssuedKey":"1978","publisher":"Elsevier ; Urban & Fischer"}],"titleAlt":[{"title":"Pathology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"8","volume":"238","year":"2022","pages":"1-8","text":"238(2022) vom: Okt., Artikel-ID 154080, Seite 1-8"},"language":["eng"],"disp":"Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patientsPathology, research and practice"}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Nina Petrović, Lidija Todorović, Milica Nedeljković, Ana Božović, Zoran Bukumirić, Nasta Dedović Tanić, Snežana Jovanović-Ćupić, Ahmad Šami, Vesna Mandušić"]},"recId":"1856822877","title":[{"title_sort":"Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients","title":"Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients"}],"note":["Online verfügbar: 17 August 2022, Artikelversion: 19 August 2022","Gesehen am 21.08.2023"],"origin":[{"dateIssuedDisp":"17 August 2022","dateIssuedKey":"2022"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"display":"Petrović, Nina","family":"Petrović","role":"aut","given":"Nina"},{"family":"Todorović","display":"Todorović, Lidija","given":"Lidija","role":"aut"},{"role":"aut","given":"Milica","display":"Nedeljković, Milica","family":"Nedeljković"},{"family":"Božović","display":"Božović, Ana","given":"Ana","role":"aut"},{"family":"Bukumirić","display":"Bukumirić, Zoran","given":"Zoran","role":"aut"},{"role":"aut","given":"Nasta Dedović","display":"Tanić, Nasta Dedović","family":"Tanić"},{"given":"Snežana","role":"aut","display":"Jovanović-Ćupić, Snežana","family":"Jovanović-Ćupić"},{"family":"Šami","display":"Šami, Ahmad","given":"Ahmad","role":"aut"},{"family":"Mandušić","display":"Mandušić, Vesna","role":"aut","given":"Vesna"}]} 
SRT |a PETROVICNIDUALFUNCTI1720